You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Health

  • Artificial sweeteners linked with spikes in blood sugar
    Artificial sweeteners might be triggering higher blood sugar levels in some people and contributing to the problems they were designed to combat, such as diabetes and obesity, according to new findings published Wednesday in the journal Nature.
  • End-of-life care lagging, poll says, urging change
    Americans aren’t getting the support and services they need as death nears, according to a U.S. report calling for an overhaul to the nation’s expensive and inefficient approach to end-of-life care.
  • Study: Artificial Sweeteners may promote diabetes
    Using artificial sweeteners may set the stage for diabetes in some people by hampering the way their bodies handle sugar, suggests a preliminary study done mostly in mice.
Advertisement

Implant maker to hire 50 by 2015

Iconacy Orthopedic Implants LLC today announced plans to create up to 50 new jobs by 2015 following its $2.63 million investment to set up a manufacturing operation in Warsaw.

The orthopedic manufacturer leased, renovated and equipped a 50,000-square-foot factory at 4130 Corridor Drive. The facility, which makes hip replacement products and surgical instruments, opened last month.

Iconacy now employs 14 and plans to begin additional hiring next year. Positions will include production, engineering, finance, marketing and administration.

The company was founded in 2009 by Tom Allen, who is now president and CEO; Dr. Roy Hori; Dr. W. Andrew Hodge; and Ann Harman. The company’s I-Hip total hip replacement system was created as a lower-cost, U.S.-manufactured option to similar products on the market.

“As the health care landscape changes over the next three or more years, we are poised to be the nimble player in a market driven by diminishing reimbursement and complex distribution models,” Allen said in a statement.

For more on this story, see Tuesday’s print edition of The Journal Gazette or visit www.journalgazette.net after 3 a.m. Tuesday.

sslater@jg.net

Advertisement